Last A$0.0010 AUD
Change Today 0.00 / 0.00%
Volume 0.0
HTX On Other Exchanges
Symbol
Exchange
Berlin
As of 8:04 PM 04/29/13 All times are local (Market data is delayed by at least 15 minutes).

healthlinx ltd (HTX) Snapshot

Open
A$0.0010
Previous Close
A$0.0010
Day High
A$0.0010
Day Low
A$0.0010
52 Week High
05/18/12 - A$0.0070
52 Week Low
10/3/12 - A$0.0010
Market Cap
969.1K
Average Volume 10 Days
0.0
EPS TTM
A$-0.0089
Shares Outstanding
969.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HEALTHLINX LTD (HTX)

Related News

No related news articles were found.

healthlinx ltd (HTX) Related Businessweek News

No Related Businessweek News Found

healthlinx ltd (HTX) Details

HealthLinx Limited, a biomarker and diagnostic company, focuses on the development of novel blood based diagnostics for targeted diseases that have un-met market need. It develops novel, non-invasive, serum-based, diagnostic products. The company offers OvPlex, a diagnostic test for the early detection of ovarian cancer in symptomatic women. It also develops AGR2, a tumour-related protein that has been shown to be upregulated in various human cancers, including carcinoma of the ovary, prostate, and breast. HealthLinx Limited markets its OvPlex in Australia, Singapore, the United Kingdom, and the Republic of Ireland. It has a licensing agreement with Millipore to use AGR2 as a research tool; and licensing/distribution agreements with Medison Pharma to distribute OvPlex in Israel and with SCL to distribute OvPlex in South Korea. The company is based in Richmond, Australia.

healthlinx ltd (HTX) Top Compensated Officers

Finance Manager
Total Annual Compensation: A$53.6K
Company Secretary and Non Executive Director
Total Annual Compensation: A$50.0K
Chief Scientific Officer
Total Annual Compensation: A$180.7K
Compensation as of Fiscal Year 2012.

healthlinx ltd (HTX) Key Developments

Healthlinx Limited Announces Board Changes

HealthLinx Limited announced the resignation of director, Mr. Nick Gatsios effective immediately. The Board announced the appointment of Mr. Trent Telford and Mr. Richard Revelins as directors effective immediately. Mr. Telford is a resident of Sydney and is a founder and director of Australian based technology companies, including Cocoon Data Limited. Mr. Revelins is a resident of California and has over 25 years experience in raising capital for ASX listed companies. He is an executive director and principal of Peregrine Corporate Limited.

HealthLinx Limited Reports Consolidated Earnings Results for the Six Months Ended December 31, 2012

HealthLinx Limited reported consolidated earnings results for the six months ended December 31, 2012. For the period, the company reported revenue of AUD 22,067 against AUD 177,343 for the same period last year. Total revenue and other income was AUD 86,774 against AUD 180,343 for the same period last year. Loss before income tax was AUD 3,177,949 against AUD 1,162,406 for the same period last year. Net loss was AUD 2,775,578 or 0.004 cents per basic and diluted share against AUD 825,997 or 0.007 cents per basic and diluted share for the same period last year. Net cash used in operating activities was AUD 554,094 against AUD 1,189,189 for the same period last year. Payments for intangibles were AUD 56,988 against AUD 112,827 for the same period last year.

HealthLinx Limited to Report First Half, 2013 Results on Feb 28, 2013

HealthLinx Limited announced that they will report first half, 2013 results on Feb 28, 2013

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HTX:AU A$0.00 AUD 0.00

HTX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HTX.
View Industry Companies
 

Industry Analysis

HTX

Industry Average

Valuation HTX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.5x
Price/Book 4.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 7.2x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEALTHLINX LTD, please visit www.healthlinx.com.au. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.